In light of the tremendous public funding and strong support for vaccines from state and federal authorities, it is not clear
whether immunization programs have a moral obligation to screen for genetic risk factors, even if screening is not cost - effective.
Not exact matches
Given the recent findings of Sanofi Pasteur and recommendations of the WHO, we support the DOH decision to suspend its Dengvaxia
immunization program until there is a quick and cost - effective way to determine
whether a person has had dengue in the past or not.
A key issue the Senate committee will consider is
whether Congress should continue the immunity it granted in 1986 to the pharmaceutical industry for claims by parents on damage to their children from the U.S. National
Immunization Program.